These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immunogenetic basis of the seronegative spondyloarthropathies. Ivanyi P. Curr Opin Rheumatol; 1992 Aug; 4(4):484-93. PubMed ID: 1503871 [Abstract] [Full Text] [Related]
23. Combined effects of ankylosing spondylitis-associated ERAP1 polymorphisms outside the catalytic and peptide-binding sites on the processing of natural HLA-B27 ligands. Martín-Esteban A, Gómez-Molina P, Sanz-Bravo A, López de Castro JA. J Biol Chem; 2014 Feb 14; 289(7):3978-90. PubMed ID: 24352655 [Abstract] [Full Text] [Related]
29. [New aspects in the pathogenesis of Bechterew disease]. Märker-Hermann E, Sucké B, Meyer zum Büschenfelde KH. Z Rheumatol; 1996 Sep 14; 55(1):4-18. PubMed ID: 8868146 [Abstract] [Full Text] [Related]
30. [The immunogenetics of ankylosing spondylitis]. Toussirot E, Wendling D. Rev Med Interne; 2006 Oct 14; 27(10):762-71. PubMed ID: 16782239 [Abstract] [Full Text] [Related]
31. HLA-B27 and HLA-B73 polymorphism and its role on antigenicity, peptide presentation, and disease susceptibility. Lopez De Castro JA. Clin Rheumatol; 1996 Jan 14; 15 Suppl 1():67-71. PubMed ID: 8835507 [Abstract] [Full Text] [Related]
33. Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. Reveille JD, Maganti RM. Adv Exp Med Biol; 2009 Jan 14; 649():159-76. PubMed ID: 19731628 [Abstract] [Full Text] [Related]
34. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Martinez-Borra J, Gonzalez S, López-Vazquez A, Gelaz MA, Armas JB, Kanga U, Mehra NK, López-Larrea C. Hum Immunol; 2000 Feb 14; 61(2):131-9. PubMed ID: 10717805 [Abstract] [Full Text] [Related]
35. Molecular mechanism of the susceptibility difference between HLA-B*27:02/04/05 and HLA-B*27:06/09 to ankylosing spondylitis: substitution analysis, MD simulation, QSAR modelling, and in vitro assay. Cheng X, Mei Y, Ji X, Xue Q, Chen D. SAR QSAR Environ Res; 2016 May 14; 27(5):409-25. PubMed ID: 27228481 [Abstract] [Full Text] [Related]
37. Differences in Cellular Clearing Mechanisms of Aggregates of Two Subtypes of HLA-B27. Thakur AK, Luthra-Guptasarma M. Front Immunol; 2021 May 14; 12():795053. PubMed ID: 35082784 [Abstract] [Full Text] [Related]
38. T-cell responses against viral and self-epitopes and HLA-B27 subtypes differentially associated with ankylosing spondylitis. Fiorillo MT, Sorrentino R. Adv Exp Med Biol; 2009 May 14; 649():255-62. PubMed ID: 19731635 [Abstract] [Full Text] [Related]
39. HLA B27 in health and disease: a double-edged sword? Bowness P. Rheumatology (Oxford); 2002 Aug 14; 41(8):857-68. PubMed ID: 12154202 [Abstract] [Full Text] [Related]
40. [Ankylosing spondylitis and heterogenity of HLA-B27 in Chinese]. Lin J, Lu H, Feng C. Zhonghua Wai Ke Za Zhi; 1996 Jun 14; 34(6):333-5. PubMed ID: 9594171 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]